Form 4: Veradigm CEO Awarded 571,428 Restricted Stock Units

Veradigm Inc. CEO Donald Trigg received an award of 571,428 restricted stock units, vesting over four years, as part of the company's 2024 Stock Incentive Plan.

Summary

• Donald Trigg, the Chief Executive Officer and a Director of Veradigm Inc., was awarded 571,428 shares of common stock in the form of Restricted Stock Units (RSUs).
• The transaction occurred on September 2, 2025, with a deemed price of $5.25 per share.
• These RSUs were granted under the Veradigm, Inc. Amended and Restated 2024 Stock Incentive Plan.
• The grant vests 25% on each of the first four anniversaries of the Grant Date (September 2, 2025).
• Following this transaction, Donald Trigg beneficially owns 571,428 shares directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned arrangement for the acquisition of equity securities.

Sentiment

Score: 7

Explanation: The RSU grant to the CEO is a positive for long-term management alignment and retention, reflecting a standard executive incentive practice.

Positives

• The award of restricted stock units to the CEO aligns management's interests with long-term shareholder value.
• The grant is part of a pre-planned equity incentive program (2024 Stock Incentive Plan), indicating structured and transparent compensation practices.
• The four-year vesting schedule encourages long-term commitment and performance from the CEO, fostering stability in leadership.

Future Outlook

The vesting schedule for the Restricted Stock Units indicates a future commitment from the CEO over the next four years, aligning his incentives with the company's long-term performance and strategic objectives.

Industry Context

Equity compensation, particularly through Restricted Stock Units with multi-year vesting schedules, is a standard practice in the healthcare IT and software industry. This approach is widely used to attract, retain, and incentivize key executives, aligning Veradigm's compensation structure with common industry standards for executive talent management.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) for executive compensation is a common practice across the technology and healthcare sectors, aligning with compensation strategies at companies such as Cerner (now Oracle Health) and Allscripts (Veradigm's former parent company).
• A four-year vesting schedule is typical for executive equity grants, comparable to practices at major tech and healthcare firms like Microsoft or Google, ensuring long-term executive retention and performance alignment.
• The size of the grant for a CEO of a company like Veradigm is within the expected range for executive compensation packages in the mid-cap healthcare IT space, similar to grants observed at companies such as NextGen Healthcare or Evolent Health.

Corporate Governance

Related Party Transactions

• The award of Restricted Stock Units to the Chief Executive Officer is a transaction with a related party, which is a standard form of executive compensation.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of the CEO's interests with long-term shareholder value through equity incentives.
• Employees: May signal stability in executive leadership and a commitment to long-term growth, potentially boosting morale and confidence.

Next Steps

• The Restricted Stock Units will vest 25% on each of the first four anniversaries of September 2, 2025.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned equity compensation grant to the CEO, which is a standard practice for executive incentives and aligns management's long-term interests with shareholders. It does not contain new operational or financial performance data that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as it provides no new information to alter existing positions.

Keywords

Veradigm, MDRX, Donald Trigg, CEO, Restricted Stock Units, RSU, Stock Incentive Plan, Insider Transaction, Form 4, Equity Compensation, Corporate Governance